Virtu Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Virtu Financial’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-74,354	Closed	-$170K	–	2041
2024 Q2	$170K	Buy	+74,354	New	+$284K	0.01%	754
2024 Q1	–	Sell	-44,726	Closed	-$136K	–	2292
2023 Q4	$136K	Buy	+44,726	New	+$84K	0.01%	957
2022 Q4	–	Sell	-34,923	Closed	-$436K	–	2276
2022 Q3	$436K	Buy	34,923 +24,842	+246%	+$284K	0.04%	462
2022 Q2	$50K	Buy	+10,081	New	+$55.8K	﹤0.01%	1126
2018 Q2	–	Sell	-7,799	Closed	-$289K	–	2604
2018 Q1	$289K	Buy	+7,799	New	+$208K	0.02%	1078

Virtu Financial's GTHX Position: Q3 2024 in Review

Virtu Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 74,354 shares — an estimated $170K sold.

Virtu Financial first reported a position in GTHX in Q1 2018 and held it in 5 quarters. The position peaked at $436K in Q3 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Virtu Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Virtu Financial sold 74,354 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $170K.
Virtu Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Virtu Financial's G1 Therapeutics, Inc. Common Stock position peaked at $436K in Q3 2022.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.